EDGAR Filing Documents for 0001062993-23-001384

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001062993-23-001384

Filing Date

2023-01-25

Accepted

2023-01-25 17:25:25

Documents

Period of Report

2023-01-23

Document Format Files

Seq	Description	Document	Type	Size
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.html	4
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.xml	4	6747
	Complete submission text file	0001062993-23-001384.txt		8256

Mailing Address 80 W. LANCASTER AVENUE, SUITE 300 DEVON PA 19333

Business Address

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 23553270

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333

Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505

Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations